A prospective, multicenter, open-label assessment of atomoxetine in non-North American children and adolescents with ADHD
- 1 August 2004
- journal article
- clinical trial
- Published by Springer Nature in European Child & Adolescent Psychiatry
- Vol. 13 (4), 249-257
- https://doi.org/10.1007/s00787-004-0401-3
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Atomoxetine in the Treatment of Children and Adolescents With Attention-Deficit/Hyperactivity Disorder: A Randomized, Placebo-Controlled, Dose-Response StudyPediatrics, 2001
- A 14-Month Randomized Clinical Trial of Treatment Strategies for Attention-Deficit/Hyperactivity DisorderArchives of General Psychiatry, 1999
- Test-Retest Reliability of the Multidimensional Anxiety Scale for ChildrenJournal of Anxiety Disorders, 1999
- ADHD in a School Sample of Brazilian Adolescents: A Study of Prevalence, Comorbid Conditions, and ImpairmentsJournal of the American Academy of Child & Adolescent Psychiatry, 1999
- Clinical guidelines for hyperkinetic disorderEuropean Child & Adolescent Psychiatry, 1998
- Neurobiology of attention-deficit hyperactivity disorderBiological Psychiatry, 1998
- Long-term Stimulant Treatment of Children With Attention-Deficit Hyperactivity Disorder SymptomsArchives of General Psychiatry, 1997
- Attention deficit hyperactivity disorder adults: Comorbidities and adaptive impairmentsComprehensive Psychiatry, 1996
- A Double-blind, Crossover Comparison of Methylphenidate and Placebo in Adults With Childhood-Onset Attention-Deficit Hyperactivity DisorderArchives of General Psychiatry, 1995
- ADHD-related behavior among non-referred children: Parents' ratings of DSM-III-R symptomsChild Psychiatry and Human Development, 1994